Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Kroger
KR
$36.4B
| $205M | 0.05% |
7,029,894
-591,143
| -8% | -$17.6M |
2013 Q2
21 quarters
|
|
352
Invesco Senior Loan ETF
BKLN
$6.28B
| $204M | 0.05% |
8,794,992
+1,210,559
| +16% | +$27.9M |
2013 Q2
21 quarters
|
|
353
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.91B
| $203M | 0.05% |
21,377,901
+315,697
| +1% | +$3.02M |
2013 Q2
21 quarters
|
|
354
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.27B
| $202M | 0.05% |
2,774,958
-66,666
| -2% | -$4.81M |
2013 Q2
21 quarters
|
|
355
iShares Gold Trust
IAU
$62.2B
| $202M | 0.05% |
8,837,083
+1,422,870
| +19% | +$33.1M |
2013 Q2
21 quarters
|
|
356
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $202M | 0.05% |
9,798,421
+911,874
| +10% | +$18.7M |
2014 Q2
17 quarters
|
|
357
Canopy Growth
CGC
$350M
| $202M | 0.05% |
414,469
+293,728
| +243% | +$109M |
2018 Q2
1 quarter
|
|
|
FDC
358
DELISTED
First Data Corporation
FDC
| $201M | 0.05% |
8,211,648
+2,939,632
| +56% | +$70.9M |
2015 Q4
11 quarters
|
|
359
iShares MSCI Taiwan ETF
EWT
$12.5B
| $200M | 0.05% |
5,311,060
+420,864
| +9% | +$15.6M |
2013 Q2
21 quarters
|
|
360
Ovintiv
OVV
$17.7B
| $200M | 0.05% |
3,045,738
-847,133
| -22% | -$54.9M |
2013 Q2
21 quarters
|
|
361
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.51B
| $198M | 0.05% |
3,676,533
+19,389
| +0.5% | +$1.04M |
2013 Q2
21 quarters
|
|
362
Vanguard Total International Stock ETF
VXUS
$163B
| $198M | 0.05% |
3,671,173
-461,090
| -11% | -$25M |
2013 Q2
21 quarters
|
|
363
Dentsply Sirona
XRAY
$1.76B
| $198M | 0.05% |
5,242,702
+4,849,652
| +1,234% | +$202M |
2013 Q2
21 quarters
|
|
364
Northern Trust
NTRS
$30.8B
| $197M | 0.05% |
1,933,544
+1,022,270
| +112% | +$109M |
2013 Q2
21 quarters
|
|
365
iShares Russell 1000 ETF
IWB
$49.7B
| $195M | 0.05% |
1,206,582
-318,143
| -21% | -$50.5M |
2013 Q2
21 quarters
|
|
366
Ameriprise Financial
AMP
$44.2B
| $195M | 0.05% |
1,318,874
-112,638
| -8% | -$16.1M |
2013 Q2
21 quarters
|
|
367
iShares MSCI Europe Financials ETF
EUFN
$3.79B
| $192M | 0.05% |
9,484,169
-1,755,644
| -16% | -$35.8M |
2013 Q2
21 quarters
|
|
368
Apollo Global Management
APO
$70.1B
| $191M | 0.05% |
5,519,866
-16,190
| -0.3% | -$564K |
2013 Q2
21 quarters
|
|
369
CME Group
CME
$101B
| $190M | 0.05% |
1,118,708
+190,256
| +20% | +$32M |
2013 Q2
21 quarters
|
|
370
General Dynamics
GD
$89.6B
| $188M | 0.05% |
916,988
+15,746
| +2% | +$3.08M |
2013 Q2
21 quarters
|
|
371
Regeneron Pharmaceuticals
REGN
$76.9B
| $188M | 0.05% |
464,603
+192,236
| +71% | +$73.2M |
2013 Q2
21 quarters
|
|
372
iShares Core High Dividend ETF
HDV
$14.9B
| $187M | 0.05% |
10,300,840
+816,325
| +9% | +$14.5M |
2013 Q2
21 quarters
|
|
373
TotalEnergies
TTE
$190B
| $186M | 0.05% |
2,895,594
-218,911
| -7% | -$13.7M |
2013 Q2
21 quarters
|
|
374
Cigna
CI
$74.6B
| $186M | 0.05% |
893,100
+125,427
| +16% | +$23.3M |
2013 Q2
21 quarters
|
|
375
Elevance Health
ELV
$89.5B
| $185M | 0.05% |
676,812
+268,900
| +66% | +$69.8M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.